Sarcoma News

Palliative radiation therapy for high-risk asymptomatic bone metastases significantly prolonged OS while reducing skeletal-related events compared with standard therapy, phase 2 trial results showed.

Proton FLASH radiotherapy showed clinical feasibility in a first-in-human study of patients with cancer and painful bone metastases, according to data presented at American Society for Radiation Oncology Annual Meeting.

BOSTON — Excisional biopsies of soft tissue sarcoma of the hand are associated with more positive margins and a longer time to patients’ first intervention vs. incisional/needle biopsies, results of a study showed.

The FDA approved sodium thiosulfate to reduce risk for cisplatin-associated ototoxicity among certain children with cancer.

It is well known that obesity, physical inactivity and a poor diet increase the risk for various cancer types and contribute to adverse outcomes among adults with certain malignancies.

Nirogacestat significantly improved PFS compared with placebo among patients with progressing desmoid tumors, according to phase 3 study results presented at ESMO Congress.

A novel multicancer early detection blood test identified a common signal for more than 50 cancer types and predicted where the signal originated in the body among individuals with undiagnosed cancer.

Crystal L. Mackall, MD, will receive Sarcoma Foundation of America’s Nobility in Science Award.

September is Childhood Cancer Awareness Month.

Despite recommendations in clinical guidelines, a high proportion of patients with advanced cancer do not have appropriate conversations with health care providers about prognosis, treatment options and end-of-life preferences.